Study Notes Pharm.D GCUF FAISALABAD

Looking for study notes for Pharm.D at GCUF, Faisalabad? Discover valuable tips and resources to enhance your study habits and excel academically. Pharm.D student at Government College University Faisalabad (GCUF) looking for effective study notes?.Effective study notes are essential for students pursuing a Pharm.D degree. They serve as a valuable tool for revision, helping you to consolidate and retain important information. By taking good study notes, you can enhance your understanding of complex topics, improve your memory retention, and boost your overall academic performance.

PHARM 310: PHARMACEUTICS-IA (PHYSICAL PHARMACY) – DETAILED NOTES

Course Title: Pharmaceutics-IA (Physical Pharmacy)
Course Code: PHARM 310
Credit Hours: 03

1. PHARMACY ORIENTATION

This section provides a foundational understanding of the various career paths and scopes within the pharmacy profession.

Introduction to the Profession of Pharmacy:
- Pharmacy is a health profession that bridges the health sciences with the chemical sciences. It is charged with ensuring the safe and effective use of pharmaceutical drugs.
- The role of a pharmacist has evolved from a traditional compounder and dispenser of medicines to a highly skilled healthcare professional, often referred to as a pharmaceutical care provider or clinical pharmacist.
Hospital Pharmacy:
- Definition: A department or service within a hospital under the direction of a qualified pharmacist. Its primary goal is to ensure the safe, appropriate, and cost-effective use of medicines in the hospital.
- Key Functions:
  - Procurement & Storage: Selecting, purchasing, and properly storing all pharmaceuticals and related supplies.
  - Dispensing: Preparing and dispensing medications for inpatients and outpatients.
  - Manufacturing: Preparing sterile products (e.g., IV solutions, TPN) and non-sterile formulations (e.g., ointments, mixtures) as needed.
  - Clinical Services: Providing drug information to physicians and nurses, monitoring patient drug therapy, participating in medical rounds, and counseling patients on discharge.
  - Inventory Control: Managing stock levels to prevent shortages and wastage.
Retail/Community Pharmacy:
Industrial Pharmacy:
- Definition: The sector of pharmacy involved in the research, development, manufacturing, quality control, and marketing of pharmaceutical products on a large scale.
- Key Functions:
  - Research & Development (R&D): Discovering and formulating new drug molecules into safe and effective dosage forms (tablets, capsules, injectables, etc.).
  - Formulation Development: Developing stable, bioavailable, and manufacturable formulations.
  - Production/Manufacturing: Large-scale manufacturing of pharmaceutical products following Good Manufacturing Practices (GMP).
  - Quality Control (QC) & Quality Assurance (QA): Testing raw materials and finished products to ensure they meet required specifications (QC); ensuring the entire manufacturing process is robust and compliant (QA).
  - Regulatory Affairs: Handling the documentation and processes required to get regulatory approval (e.g., from the FDA or DRAP) to market a drug.
Forensic Pharmacy:
Pharmaceutical Education and Research:
- Education: Involves training future pharmacists and pharmaceutical scientists. It ranges from undergraduate (Pharm-D, B.Pharm) to postgraduate (M.Pharm, M.S., Ph.D.) levels. It combines theoretical knowledge with practical skills.
- Research: The engine of progress in pharmacy. It can be:
  - Basic Research: Discovering new drug targets or molecules.
  - Applied Research: Developing new formulations, drug delivery systems, or analytical methods.
  - Clinical Research: Testing new drugs in humans to determine their safety and efficacy.

2. HISTORY AND LITERATURE OF PHARMACY

This section connects the past to the present, acknowledging the roots of the profession and introducing its core reference texts.

a. History of Pharmacy

b. Introduction to Various Official Books (Pharmacopoeias)

An official book, or pharmacopoeia, is a legally recognized compendium of standards for drugs, their preparations, dosage forms, and other related articles. It ensures uniformity and quality in pharmaceuticals.
Key International Pharmacopoeias:
- British Pharmacopoeia (BP): The official drug standard for the United Kingdom. Widely used in many Commonwealth countries.
- United States Pharmacopeia–National Formulary (USP–NF): The official drug standards for the United States. USP sets standards for drugs, while the NF sets standards for excipients (inactive ingredients).
- European Pharmacopoeia (Ph. Eur.): A binding legal standard for its member states in Europe.
- International Pharmacopoeia (Ph. Int.): Published by the World Health Organization (WHO). It is not legally binding but provides recommended quality specifications for member states, especially useful for developing countries.
National Pharmacopoeia:
Other Official Literature:
- National Formulary (NF): A book of official standards for pharmaceutical excipients.
- British Pharmaceutical Codex (BPC): Historically provided information on drugs not included in the BP, as well as formulary standards. Now largely replaced by other resources.
- Martindale: The Complete Drug Reference: A comprehensive reference book providing detailed information on drugs and medicines used worldwide, including indications, adverse effects, and proprietary preparations.
- Merck Index: An encyclopedia of chemicals, drugs, and biologicals, providing concise monographs on their properties and uses.

3. PHYSICO-CHEMICAL PRINCIPLES

This is the core of Physical Pharmacy, applying chemistry and physics to pharmaceutical systems.

a. Solutions

Introduction: A solution is a homogenous mixture of two or more substances. It consists of a solute (the substance being dissolved) and a solvent (the medium in which the solute is dissolved).
Types:
- Based on solvent: Aqueous (water), Alcoholic (alcohol), Glycerites (glycerin).
- Based on solute state: Solid in liquid (salt water), Liquid in liquid (alcohol in water), Gas in liquid (carbonated water).
Concentration Expressions:
- Molarity (M): Moles of solute per liter of solution.
- Molality (m): Moles of solute per kilogram of solvent.
- Normality (N): Gram equivalents of solute per liter of solution.
- Percentage Expressions:
  - % w/w (weight in weight): grams of solute per 100 g of solution.
  - % w/v (weight in volume): grams of solute per 100 mL of solution.
  - % v/v (volume in volume): mL of solute per 100 mL of solution.
- Mole Fraction: Ratio of the number of moles of one component to the total number of moles in the solution.
Ideal and Real Solutions:
- Ideal Solution: Obeys Raoult’s law perfectly over the entire range of concentration. The intermolecular forces between A-A, B-B, and A-B are all equal. There is no change in volume or heat upon mixing.
- Real Solution: Deviates from Raoult’s law. The intermolecular forces are not equal, leading to positive or negative deviations.
Colligative Properties: Properties that depend only on the number of solute particles in a solution, not on their identity. They are crucial for calculating molecular weights and preparing isotonic solutions.
- 1. Vapor Pressure Lowering: Raoult’s law states that the vapor pressure of a solvent over a solution (P₁) is equal to the vapor pressure of the pure solvent (P₁°) multiplied by its mole fraction (X₁). The relative lowering of vapor pressure is equal to the mole fraction of the solute.
- 2. Boiling Point Elevation: The boiling point of a solution is higher than that of the pure solvent.
  - Equation: ΔTb = Kb * m
  - ΔTb = boiling point elevation
  - Kb = ebullioscopic constant (specific to the solvent)
  - m = molality of the solution
- 3. Freezing Point Depression: The freezing point of a solution is lower than that of the pure solvent.
- 4. Osmotic Pressure (π): The pressure required to prevent the flow of solvent into a solution across a semipermeable membrane. It is the most important colligative property for biological systems.
Applications in Pharmacy:
- Determining the molecular weight of unknown compounds (especially polymers and proteins).
- Formulating isotonic solutions (like eye drops and injectables) that have the same osmotic pressure as body fluids (e.g., blood, tears) to prevent cell damage or pain.
Distribution Coefficient (Partition Coefficient):
- Definition: When a solute is added to a mixture of two immiscible solvents, it distributes itself between them. The distribution coefficient (K) is the ratio of the concentrations of the solute in each solvent at equilibrium. K = C₁ / C₂ (where C₁ and C₂ are concentrations in solvent 1 and solvent 2).
- Applications in Pharmacy:
  - Drug Absorption: Predicting how a drug will partition between the aqueous environment of the gut and the lipid membranes of cells (Lipinski’s Rule of Five uses log P).
  - Extraction: Used in the isolation and purification of drugs from natural sources or reaction mixtures.
  - Preservative Activity: Determining how much of a preservative in an aqueous phase will partition into the oil phase of an emulsion, thereby reducing its effectiveness in the aqueous phase where microbes grow.

b. Solubilization

Solubility: The maximum amount of solute that can be dissolved in a given amount of solvent at a specific temperature and pressure to form a saturated solution.
Factors Affecting Solubility:
- Nature of Solute and Solvent: “Like dissolves like.” Polar/ionic solutes dissolve in polar solvents (water). Non-polar solutes dissolve in non-polar solvents (oils, hexane).
- Temperature: For most solids, solubility increases with temperature. For gases, solubility decreases with increasing temperature.
- Pressure: Mainly affects the solubility of gases (Henry’s Law: Solubility ∝ Partial pressure).
- Particle Size: For very fine particles (<1 μm), solubility can increase due to high surface free energy.
- pH: For weak acids and bases, solubility is highly dependent on the pH of the medium.
Surfactants (Surface Active Agents):
- Properties: Surfactants are molecules that have both a hydrophilic (water-loving, polar) and a lipophilic (oil-loving, non-polar) part. This dual nature makes them amphiphilic.
- Functions: They adsorb at interfaces (e.g., oil-water, air-water), reducing surface/interfacial tension. This property makes them useful as detergents, wetting agents, emulsifiers, and solubilizers.
- Types (based on the charge of the hydrophilic head):
  - Anionic: Head carries a negative charge (e.g., sodium lauryl sulfate, soaps).
  - Cationic: Head carries a positive charge (e.g., benzalkonium chloride – also used as a preservative).
  - Non-ionic: Head has no charge (e.g., polysorbates (Tweens), sorbitan esters (Spans)). They are generally less toxic and less affected by pH changes.
  - Amphoteric (Zwitterionic): Can carry a positive or negative charge depending on the pH of the solution (e.g., phospholipids, betaines).
Micelles:
- Formation: When surfactants are added to a liquid at low concentrations, they exist as monomers. At a specific concentration called the Critical Micelle Concentration (CMC) , they spontaneously self-assemble into aggregates called micelles.
- Structure:
  - In aqueous (water) solutions, the hydrophilic heads face outward, interacting with water, and the lipophilic tails are tucked away in the core (normal micelles).
  - In non-aqueous (oil) solutions, the structure reverses: hydrophilic heads face inward, and lipophilic tails face outward (reverse micelles).
- Types: Micelles can be spherical, rod-shaped, or lamellar, depending on the surfactant structure and concentration.

c. Adsorption

Definition: The process by which atoms, ions, or molecules from a gas, liquid, or dissolved solid (the adsorbate) adhere to a surface (the adsorbent). It is a surface phenomenon. Distinct from absorption, which involves the entire volume of the material.
Techniques and Processes:
- Physical Adsorption (Physisorption): Caused by weak van der Waals forces. It is reversible, multi-layered, and has low enthalpy.
- Chemical Adsorption (Chemisorption): Caused by the formation of chemical bonds. It is irreversible, forms a monolayer, and has high enthalpy.
Applications in Pharmacy:
- Purification: Removing unwanted colored impurities from solutions using charcoal (adsorbent).
- Chromatography: Separation of drug mixtures based on their differential adsorption to a stationary phase.
- Stability: Adsorption of moisture from the air by hygroscopic drugs using desiccants like silica gel.
- Antidotes: Activated charcoal is used as an antidote in poisoning cases because it can adsorb toxins in the gastrointestinal tract.
- Drug Action: The first step in the action of many drugs is adsorption to a cell surface receptor.

d. Ionization

pH: A scale used to specify the acidity or basicity of an aqueous solution. It is defined as the negative logarithm (base 10) of the hydrogen ion concentration. pH = -log [H⁺] . The scale typically runs from 0 to 14, with 7 being neutral.
pH Indicators: Weak organic acids or bases that have different colors in their ionized (conjugate base) and unionized (acid) forms. They are used to visually determine the approximate pH of a solution.
pKa (Ionization/Dissociation Constant): A measure of the strength of an acid. It is the negative logarithm of the acid dissociation constant (Ka). pKa = -log Ka . It is the pH at which half of the acid molecules are ionized and half are unionized.
Buffers:
- Definition: Solutions that resist changes in pH when small amounts of acid (H⁺) or base (OH⁻) are added to them. They consist of a weak acid and its conjugate base, or a weak base and its conjugate acid.
- Buffer Equation (Henderson-Hasselbalch Equation): For a weak acid (HA) and its salt (A⁻):
- Applications in Pharmacy:
  - Formulating stable liquid dosage forms (many drugs are most stable at a specific pH).
  - Maintaining the pH of ophthalmic and parenteral products close to physiological pH (7.4) to prevent pain and tissue damage.
  - Adjusting the pH of topical preparations to be compatible with the skin.
Isotonic Solutions:
- Definition: A solution that has the same osmotic pressure as another solution (usually a body fluid, like blood plasma or tears). An isosmotic solution has the same osmotic pressure in theory; an isotonic solution is isosmotic and also does not cause a biological response (like cell shrinkage or swelling).
- Tonicity:
  - Isotonic: No net movement of water across the cell membrane (e.g., 0.9% NaCl solution).
  - Hypotonic: Lower solute concentration outside the cell. Water moves into the cell, causing it to swell and potentially burst (hemolysis).
  - Hypertonic: Higher solute concentration outside the cell. Water moves out of the cell, causing it to shrink (crenation).
- Applications in Pharmacy: Essential for formulating ophthalmic solutions, parenteral (injectable) solutions, and nasal sprays to ensure they are safe and non-irritating.
- Methods of Adjustment: Using the freezing point depression method (ΔTf = -0.52°C for blood and tears) or the NaCl equivalent method.

e. Hydrolysis

Definition: A chemical reaction in which a compound is broken down by reaction with water. It is a major cause of drug instability.
Types:
- Ester Hydrolysis: Common in drugs containing an ester functional group (e.g., aspirin, procaine, atropine). The ester reacts with water to form an acid and an alcohol.
- Amide Hydrolysis: Drugs containing an amide group (e.g., chloramphenicol, lidocaine) hydrolyze to form an acid and an amine. Amides are generally more resistant to hydrolysis than esters.
Protection of Drugs Against Hydrolysis:
- Control of pH: Most drugs have a pH of maximum stability. Formulating the product at this optimal pH (using buffers) is the primary method.
- Use of Non-Aqueous Solvents: Replacing water with solvents like glycerin, propylene glycol, or alcohol can significantly reduce hydrolysis.
- Refrigeration: Lowering the temperature slows down the rate of the hydrolysis reaction.
- Packaging: Removing water from the formulation (anhydrous products) or protecting the drug from moisture in the air.
- Complexation: Some drugs can be stabilized by forming inclusion complexes with molecules like cyclodextrins.

f. Micromeritics

Definition: The science and technology of small particles. It deals with the fundamental properties of particles, including their size, shape, surface area, and porosity.
Particle Size, Shape, and Distribution:
- Particle Size: The diameter of a particle. Since particles are rarely perfect spheres, various “equivalent spherical diameters” are used (e.g., volume diameter, surface diameter).
- Particle Shape: Described qualitatively (e.g., spherical, acicular (needle-like), flaky, granular) or quantitatively using shape factors.
- Particle Size Distribution: Pharmaceutical powders consist of a range of particle sizes. This distribution can be represented as a frequency distribution curve (normal, log-normal) or a cumulative distribution curve. Key parameters include the mean, median, and mode.
Methods of Determination of Particle Size:
- Microscopy: Using an optical or electron microscope to measure individual particles. Simple but can be time-consuming.
- Sieving: Passing the powder through a stack of sieves with progressively smaller mesh sizes. The weight retained on each sieve gives the size distribution. Best for larger particles (>50 μm).
- Sedimentation: Based on Stokes’ Law, which relates the rate of settling of a particle in a fluid to its size. The Andreasen pipette is a common device.
- Laser Diffraction: A modern, rapid technique where a laser beam is passed through a dispersed sample. The angle and intensity of the scattered light are used to calculate particle size (based on Fraunhofer or Mie theory).
- Coulter Counter: Particles suspended in an electrolyte solution are drawn through a small aperture. As a particle passes through, it displaces its volume of electrolyte, causing a change in electrical resistance, which is counted and sized.
Importance of Particle Size in Pharmacy:
- Dissolution Rate and Bioavailability: Smaller particle size → larger surface area → faster dissolution rate. This is critical for poorly soluble drugs (e.g., griseofulvin, digoxin) to ensure they are adequately absorbed.
- Absorption: Particle size can affect the rate of drug absorption from the gastrointestinal tract.
- Content Uniformity: In a tablet or capsule containing a potent, low-dose drug, the drug powder must be very fine and mixed thoroughly with excipients to ensure each dosage unit contains the correct amount.
- Flow Properties: Particle size and shape greatly influence how a powder flows. Good flow is essential for high-speed tablet and capsule manufacturing.
- Suspension Stability: Smaller particles settle more slowly (by Brownian motion) and are less likely to settle, leading to a more physically stable suspension.
- Irritancy: Finer particles of topical drugs (like corticosteroids) may be absorbed more readily, potentially increasing their effect or irritation potential.

PHARM 311: PHARMACEUTICAL ORGANIC CHEMISTRY – DETAILED NOTES

Course Title: Pharmaceutical Organic Chemistry
Course Code: PHARM 311
Credit Hours: 03

Core Principle: This entire course is taught with a focus on how organic chemistry principles directly apply to drug action, design, stability, and formulation.

1. BASIC CONCEPTS

This section builds the fundamental language of organic chemistry, explaining why molecules have specific shapes, reactivities, and properties.

Chemical Bonding and Concept of Hybridization:
- Ionic Bond: Complete transfer of electrons (e.g., Na⁺Cl⁻). Relevant for salt formation of drugs (e.g., aspirin is a weak acid; its sodium salt is more water-soluble).
- Covalent Bond: Sharing of electrons.
- Hybridization: Mixing of atomic orbitals to form new, equivalent hybrid orbitals for bonding. This dictates molecular geometry.
  - sp³ Hybridization: Tetrahedral geometry (bond angle ~109.5°). Found in alkanes (e.g., ethane). Pharmaceutical Application: The 3D shape of a drug with sp³ carbons determines how it fits into a receptor pocket.
  - sp² Hybridization: Trigonal planar geometry (bond angle ~120°). Found in alkenes and carbonyl groups (C=O). Pharmaceutical Application: The planar structure of the benzene ring in many drugs (e.g., ibuprofen) allows for intercalation or binding via π-π stacking with aromatic amino acids in proteins.
  - sp Hybridization: Linear geometry (bond angle 180°). Found in alkynes (e.g., the antifungal drug terbinafine has an alkyne group).
Conjugation:
- Definition: An system with alternating single and multiple bonds (e.g., C=C-C=C). This allows for the delocalization of electrons across the entire system.
- Pharmaceutical Application:
  - UV-Visible Spectroscopy: Conjugated systems absorb light in the UV or visible range. This is used for the analysis and quantification of many drugs.
  - Color of Compounds: Drugs with extensive conjugation can be colored (e.g., riboflavin/vitamin B2 is yellow).
  - Stability: Conjugation can stabilize a molecule or an intermediate.
Resonance (Mesomerism):
- Definition: The delocalization of π-electrons (or lone pairs) within a molecule, leading to a more stable structure that is a hybrid of multiple contributing structures (represented by curved arrows).
- Pharmaceutical Application:
  - Stability of Benzene Ring: The resonance energy makes the benzene ring stable and a common scaffold in drug design.
  - Acidity/Basicity: The phenoxide ion (from phenol) is stabilized by resonance, making phenol more acidic than alcohols. The carboxylate ion (RCOO⁻) is resonance-stabilized, making carboxylic acids acidic.
  - Amide Bond in Peptides/Proteins: The resonance between the carbonyl and the nitrogen gives the amide bond a partial double-bond character, making it planar and rigid, which is crucial for the 3D structure of proteins.
Hyperconjugation:
- Definition: The stabilization interaction that results from the interaction of the electrons in a σ-bond (usually C-H or C-C) with an adjacent empty or partially filled p-orbital or a π-orbital.
- Pharmaceutical Application: It helps explain the relative stability of carbocations (tertiary > secondary > primary > methyl), which are key intermediates in many drug metabolic pathways and degradation reactions.
Aromaticity:
- Definition: A property of cyclic, planar molecules with a ring of resonance bonds that possesses extra stability due to a cloud of delocalized π-electrons. Must follow Hückel’s Rule (4n+2 π electrons).
- Pharmaceutical Application: A vast majority of drugs contain aromatic rings (e.g., aspirin, paracetamol, diazepam). They provide a rigid, planar structure that is excellent for binding to biological targets.
Inductive Effect:
- Definition: The permanent polarization of a σ-bond due to the electronegativity difference between atoms. It is a through-bond effect.
  - -I Effect (Electron Withdrawing): Atoms/groups more electronegative than hydrogen (e.g., -F, -Cl, -NO₂, -NH₃⁺) pull electron density away.
  - +I Effect (Electron Donating): Atoms/groups less electronegative than hydrogen (e.g., -CH₃, -C₂H₅, alkyl groups) push electron density.
- Pharmaceutical Application:
  - Effect on Acidity/Basicity: Electron-withdrawing groups (-I) near a carboxylic acid increase its acidity by stabilizing the conjugate base. Electron-donating groups (+I) near an amine increase its basicity.
  - Drug Stability: The inductive effect can influence the susceptibility of a drug to hydrolysis or oxidation.
Electromeric Effect:
- Definition: A temporary, complete transfer of π-electrons to one of the atoms bonded in a multiple bond in the presence of an attacking reagent. It is a through-space effect.
- Pharmaceutical Application: This effect explains the reactivity of carbonyl compounds (C=O) and alkenes in addition reactions, which are fundamental to how some drugs work (e.g., alkylating agents in cancer therapy) and how they are metabolized.
Hydrogen Bonding:
- Definition: A special type of dipole-dipole attraction between a hydrogen atom bonded to a highly electronegative atom (N, O, or F) and another electronegative atom.
- Pharmaceutical Application:
  - Drug-Receptor Interaction: Hydrogen bonds are one of the most important forces for binding a drug to its target protein or DNA (e.g., the binding of penicillin to bacterial enzymes).
  - Solubility: Drugs that can hydrogen bond with water (e.g., those with -OH, -NH₂ groups) are more water-soluble.
  - Protein Structure (Secondary Structure): Hydrogen bonds stabilize alpha-helices and beta-sheets in proteins.
Steric Effect:
- Definition: The influence on a molecule’s reactivity, properties, or shape due to the spatial arrangement and physical bulk of its atoms or groups.
- Pharmaceutical Application:
  - Protecting Labile Groups: Bulky groups can be attached to a drug molecule to shield an ester or amide bond from enzymatic attack (hydrolysis), prolonging its duration of action (prodrug design).
  - Receptor Binding: A drug must have the correct shape to fit into a receptor. A bulky group in the wrong place can prevent binding (steric hindrance), while in the right place, it can enhance binding (steric fit).
Effect of Structure on Reactivity of Compounds:
- This is the culmination of all the above concepts. The reactivity of a functional group is profoundly affected by the atoms and groups attached to it via inductive, mesomeric, and steric effects.
Tautomerism of Carbonyl Compounds:
- Definition: A special type of isomerism where isomers (tautomers) are in rapid equilibrium and readily interconvert by the migration of an atom (usually hydrogen) and a shift of a double bond.
- Keto-Enol Tautomerism: The most common type, where a keto form (C=O) is in equilibrium with an enol form (C=C-OH). The keto form is usually more stable.
- Pharmaceutical Application:
  - Barbiturates: These sedative-hypnotics can exist in multiple tautomeric forms, which can affect their lipid solubility and ability to cross the blood-brain barrier.
  - Sulfa Drugs: Some sulfonamides exhibit tautomerism.
  - Reactivity: The enol form can act as a nucleophile in reactions.
Nomenclature of Organic Compounds:
- IUPAC System: The standardized method for naming organic chemicals. It is essential for identifying drugs, reading prescriptions, and understanding pharmaceutical literature.

2. STEREOCHEMISTRY / CONFORMATIONAL ANALYSIS

This is arguably the most critical section for understanding drug action, as biological systems are “stereospecific.”

3. GENERAL METHODS OF PREPARATION, PROPERTIES, IDENTIFICATION TESTS AND PHARMACEUTICAL APPLICATIONS

This section applies the concepts from Parts 1 and 2 to specific classes of organic compounds. The focus is on the functional group as the “business end” of a drug molecule.

(For each class, the following will be discussed with pharmaceutical examples)

i. Alkanes, Alkenes, Alkynes, Aromatic Compounds

Alkanes (Saturated Hydrocarbons):
- General Methods: Hydrogenation of alkenes, from alkyl halides (Wurtz reaction), from carboxylic acids (Kolbe’s electrolysis).
- Properties: Relatively inert, non-polar, hydrophobic. Undergo free radical substitution (e.g., halogenation).
- Pharmaceutical Applications:
  - Liquid Paraffin: A mixture of liquid alkanes used as a laxative.
  - Soft Paraffin (Petrolatum): A semi-solid mixture used as an ointment base (e.g., Vaseline).
  - Embedding in Drug Design: Alkyl chains (-CH₃, -C₂H₅) are used to modulate the lipophilicity of a drug molecule, affecting its absorption and distribution.
Alkenes (Unsaturated Hydrocarbons with C=C):
- General Methods: Dehydration of alcohols, dehydrohalogenation of alkyl halides.
- Properties: Reactive due to the π-bond. Undergo electrophilic addition reactions (e.g., hydrogenation, halogenation, addition of HX).
- Pharmaceutical Applications:
  - Steroids: Many steroids have double bonds essential for their shape and function.
  - Fatty Acids: Unsaturated fatty acids (with double bonds) like oleic acid are crucial components of cell membranes.
  - Drug Metabolism: Oxidation of double bonds (epoxidation) is a common metabolic pathway.
Alkynes (Unsaturated Hydrocarbons with C≡C):
- General Methods: Dehydrohalogenation of vicinal or geminal dihalides.
- Properties: Similar reactivity to alkenes. The terminal alkyne hydrogen is slightly acidic.
- Pharmaceutical Applications:
  - Antifungals: Terbinafine (for athlete’s foot) contains an alkyne group.
  - Contraceptives: Norethynodrel, a component of some early oral contraceptives, contained an alkyne.
  - Antivirals: Efavirenz (for HIV) has an alkyne group.
Aromatic Compounds (Benzene and its derivatives):
- General Methods: From petroleum, decarboxylation of aromatic acids.
- Properties: Undergo electrophilic aromatic substitution (nitration, sulfonation, halogenation, Friedel-Crafts alkylation/acylation).
- Pharmaceutical Applications: As mentioned in Aromaticity, this is the most important class. Thousands of drugs contain an aromatic ring.
  - Analgesics: Aspirin (acetylsalicylic acid)
  - Antibiotics: Chloramphenicol
  - Antihistamines: Loratadine
  - Antihypertensives: Propranolol

ii. Alkyl Halide, Alcohol, Phenols, Ethers, Amines

Alkyl Halides (Haloalkanes):
- General Methods: From alcohols (using PX₃, SOCl₂), halogenation of alkanes, addition of HX to alkenes.
- Properties: Polar bonds (C-X), undergo nucleophilic substitution (S<sub>N</sub>1/S<sub>N</sub>2) and elimination (E1/E2) reactions.
- Pharmaceutical Applications:
  - Anesthetics: Halothane, enflurane, isoflurane (volatile liquids for inhalation anesthesia).
  - Alkylating Agents in Chemotherapy: Drugs like cyclophosphamide and chlorambucil work by alkylating DNA, which prevents cancer cell replication. They are highly reactive alkyl halides.
Alcohols (-OH):
- General Methods: Hydration of alkenes, reduction of carbonyl compounds (aldehydes, ketones, acids), from Grignard reagents.
- Properties: Can form hydrogen bonds (higher boiling points). Can be oxidized. Acidity/basicity depends on structure.
- Pharmaceutical Applications:
  - Ethyl Alcohol (Ethanol): Used as a solvent (in tinctures and elixirs), disinfectant (70% solution), and antiseptic.
  - Isopropyl Alcohol (Rubbing Alcohol): Used as a disinfectant.
  - Glycerin (Glycerol – a triol): Used as a humectant (retains moisture), sweetener, and in suppositories.
  - Part of Many Drugs: The -OH group is a common feature in many drugs (e.g., morphine, sugars, steroids).
Phenols (Aromatic -OH):
- General Methods: From diazonium salts, from sulfonic acids (fusion with NaOH), from cumene.
- Properties: More acidic than alcohols due to resonance stabilization of the phenoxide ion. Can act as antioxidants.
- Pharmaceutical Applications:
  - Antiseptics/Disinfectants: Phenol (carbolic acid) was the first surgical antiseptic (Joseph Lister). Derivatives like thymol, chlorocresol, and hexachlorophene are still used.
  - Antioxidants: Butylated HydroxyToluene (BHT) and Butylated HydroxyAnisole (BHA) are phenols used to prevent oxidation of oils and drugs in formulations.
  - Analgesic: Paracetamol (acetaminophen) contains a phenolic -OH group.
Ethers (-O-):
- General Methods: Williamson ether synthesis (from alkyl halide and alkoxide), dehydration of alcohols.
- Properties: Relatively inert, good solvents for organic reactions.
- Pharmaceutical Applications:
  - Anesthetics: Diethyl ether was a historic inhalation anesthetic. Enflurane, isoflurane, and sevoflurane (modern anesthetics) are also (fluorinated) ethers.
  - Solvents: In the manufacture of pharmaceuticals.
Amines (-NH₂, -NHR, -NR₂):
- General Methods: Reduction of nitro compounds, nitriles, and amides; alkylation of ammonia; reductive amination.
- Properties: Basic (they can accept a proton). Aliphatic amines are stronger bases than aromatic amines (aniline). They are nucleophiles.
- Pharmaceutical Applications:
  - Alkaloids: A huge class of basic, nitrogen-containing drugs from plants (e.g., morphine, quinine, atropine, caffeine, nicotine).
  - Local Anesthetics: Many, like lidocaine and procaine, contain an amine group.
  - Antihistamines: Most, like diphenhydramine (Benadryl) and cetirizine (Zyrtec), contain an amine.
  - Salt Formation: The basic amine group is often converted into a water-soluble salt (e.g., hydrochloride) for formulation into tablets or injections.

iii. Ketones, Aldehydes (Carbonyl Compounds)

General Methods: Oxidation of alcohols, Friedel-Crafts acylation (for aromatic ketones), ozonolysis of alkenes, hydration of alkynes.
Properties: The polar C=O bond makes the carbonyl carbon electrophilic. They undergo nucleophilic addition reactions. Aldehydes are generally more reactive and are easily oxidized to acids; ketones are resistant to oxidation.
Pharmaceutical Applications:
- Steroids and Hormones: Many, like progesterone, testosterone, and cortisone, contain ketone groups.
- Antibiotics: Tetracyclines contain a ketone.
- Solvents: Acetone (a ketone) is used as a solvent.
- Aldehyde as a Functional Group:
  - Antibiotic: Streptomycin contains an aldehyde group.
  - Disinfectant: Formaldehyde solution (formalin) is used for disinfection and preservation.
  - Vitamin: Retinal (derived from Vitamin A) is an aldehyde crucial for vision.

iv. Acids, Esters, Amides and derivatives

Carboxylic Acids (-COOH):
- General Methods: Oxidation of primary alcohols or aldehydes, hydrolysis of nitriles, from Grignard reagents with CO₂.
- Properties: Acidic due to resonance-stabilized carboxylate ion. Can form hydrogen bonds (dimers). They react with alcohols to form esters, and with amines to form amides.
- Pharmaceutical Applications:
  - Anti-inflammatories: Ibuprofen, naproxen, and aspirin (acetylsalicylic acid, which is an ester of salicylic acid, but salicylic acid itself has a -COOH).
  - Antibiotics: Penicillins have a carboxyl group important for their activity.
  - Preservatives: Benzoic acid and sorbic acid are used as antimicrobial preservatives in foods and pharmaceuticals.
  - Fatty Acids: Building blocks of lipids.
Esters (R-COO-R’):
- General Methods: Fischer esterification (carboxylic acid + alcohol in presence of acid).
- Properties: Can be hydrolyzed back to acid and alcohol (especially in the presence of acid, base, or enzymes). Often have fruity smells.
- Pharmaceutical Applications:
  - Prodrugs: This is a major application. A drug with a polar -COOH or -OH group can be made into an ester to increase its lipophilicity and membrane permeability. Once absorbed, esterases in the body hydrolyze it to release the active drug (e.g., enalapril maleate is an ester prodrug of the active drug enalaprilat).
  - Local Anesthetics: Many, like benzocaine and procaine, are esters. (Note: Lidocaine is an amide).
  - Nitroglycerin: Used for angina, it is a nitrate ester.
  - Parabens: Esters of para-hydroxybenzoic acid, widely used as preservatives (e.g., methylparaben, propylparaben).
Amides (R-CO-NH₂, R-CO-NHR, R-CO-NR₂):
- General Methods: From carboxylic acid derivatives (acid chlorides, anhydrides, esters) with ammonia or amines.
- Properties: Much more resistant to hydrolysis than esters. The amide bond is planar and rigid due to resonance. They are neutral (not basic like amines).
- Pharmaceutical Applications:
  - The Peptide Bond: The most important amide bond in nature, linking amino acids together to form proteins and peptides (e.g., insulin, oxytocin).
  - Antibiotics: The key ring structure in penicillins and cephalosporins is a cyclic amide called a β-lactam.
  - Analgesics: Paracetamol contains an amide bond (it is actually an amide, not an amide of a carboxylic acid specifically, but an anilide).
  - Local Anesthetics: Lidocaine is an amide-type local anesthetic, which is more stable than ester-type anesthetics.
  - Barbiturates and Benzodiazepines: These important classes of CNS drugs contain multiple amide-like bonds in their ring structures.

PHARM 312: PHARMACEUTICAL CHEMISTRY-IIA (BIOCHEMISTRY) – DETAILED NOTES

Course Title: Pharmaceutical Chemistry-IIA (Biochemistry)
Course Code: PHARM 312
Credit Hours: 03

1. GENERAL INTRODUCTION AND BASIC BIOCHEMICAL PRINCIPLES

2. BASIC CHEMISTRY OF BIOMOLECULES

a) Carbohydrates

b) Lipids

Chemistry of Fatty Acids and Lipids:
- Lipids: A heterogeneous group of compounds that are insoluble in water but soluble in non-polar organic solvents (e.g., ether, chloroform).
- Fatty Acids: Building blocks of many complex lipids. They are long-chain carboxylic acids.
  - Saturated: No double bonds (e.g., Palmitic acid, Stearic acid). Solid at room temperature.
  - Unsaturated: One or more double bonds (e.g., Oleic acid (one), Linoleic acid (two)). Usually liquid at room temperature (oils).
Classification:
- Saponifiable Lipids: Contain ester bonds and can undergo hydrolysis (saponification) to produce soaps.
- Non-Saponifiable Lipids: Cannot be hydrolyzed; do not contain ester bonds.
  - Steroids: Structure based on a cyclopentanoperhydrophenanthrene ring (e.g., Cholesterol, bile acids, steroid hormones).
  - Terpenes (e.g., essential oils)
  - Eicosanoids (e.g., Prostaglandins)
- Derived Lipids: Substances derived from simple and complex lipids by hydrolysis (e.g., fatty acids, glycerol, steroids).
Reactions of Fatty Acids and other Lipids:
- Esterification: Formation of esters (e.g., triglycerides).
- Hydrolysis (Saponification): Breakdown of ester bonds by alkali to produce glycerol and soaps (salts of fatty acids).
- Hydrogenation: Addition of hydrogen to unsaturated fatty acids, converting liquid oils into solid fats (e.g., making margarine).
- Rancidity: Oxidative or hydrolytic breakdown of lipids, leading to unpleasant odors and tastes.
Essential Fatty Acids (EFAs):
Biological and Pharmaceutical Importance:
- Energy Storage: Concentrated energy reserve in adipose tissue.
- Structural Components: Phospholipids and cholesterol are the main structural components of all cell membranes, controlling membrane fluidity and permeability.
- Precursors: Cholesterol is a precursor for bile acids (digestion), steroid hormones (e.g., cortisol, estrogen, testosterone), and Vitamin D.
- Protection and Insulation: Cushion internal organs and provide thermal insulation.
- Excipients:
  - Oils (e.g., vegetable oils, mineral oil) used as vehicles.
  - Waxes (e.g., beeswax) used in ointments and creams.
  - Lecithin (a phospholipid) used as an emulsifier and stabilizer.
  - Lipid-Based Drug Delivery Systems: Liposomes (tiny spherical vesicles made of phospholipids) are used to encapsulate drugs for targeted delivery and improved efficacy (e.g., Doxil – liposomal doxorubicin).
- Fat-Soluble Vitamin Carriers: Essential for the absorption of Vitamins A, D, E, and K.

c) Proteins and Amino acids

Chemistry of Amino Acids:
- Amino acids are organic compounds containing a central carbon (α-carbon) bonded to an amino group (-NH₂), a carboxyl group (-COOH), a hydrogen atom, and a variable R-group (side chain) .
- Classification of Amino Acids: Based on the properties of the R-group.
  - Non-polar, Aliphatic R-group (e.g., Glycine, Alanine, Valine, Leucine)
  - Aromatic R-group (e.g., Phenylalanine, Tyrosine, Tryptophan)
  - Polar, Uncharged R-group (e.g., Serine, Cysteine, Glutamine)
  - Positively Charged (Basic) R-group (e.g., Lysine, Arginine)
  - Negatively Charged (Acidic) R-group (e.g., Aspartic acid, Glutamic acid)
Chemistry of Proteins:
- Proteins are linear polymers of amino acids linked by peptide bonds (amide bonds formed between the α-carboxyl of one amino acid and the α-amino of another).
- Reactions of Proteins and Amino Acids:
  - Ninhydrin Reaction: All amino acids and proteins react with ninhydrin to produce a purple color. Used for detection and quantification.
  - Biuret Test: Peptide bonds react with copper sulfate in alkaline solution to give a violet color. Used to detect proteins.
  - Xanthoproteic Test: Aromatic amino acids (tyrosine, tryptophan) turn yellow upon addition of concentrated nitric acid.
  - Specific reactions for certain R-groups (e.g., Millon’s test for tyrosine, Sakaguchi test for arginine).
Classification of Proteins:
- Based on Shape:
  - Fibrous Proteins: Long, insoluble, structural proteins (e.g., Collagen, Keratin, Elastin).
  - Globular Proteins: Compact, spherical, usually soluble and functionally active (e.g., Enzymes, Hemoglobin, Albumin, Antibodies).
- Based on Composition:
  - Simple Proteins: Yield only amino acids on hydrolysis (e.g., Albumin, Globulin).
  - Conjugated Proteins: Contain a non-protein part (prosthetic group) (e.g., Hemoglobin (heme), Glycoproteins (carbohydrate), Lipoproteins (lipid)).
Organizational Levels (Protein Structure):
- Primary Structure: The linear sequence of amino acids in the polypeptide chain.
- Secondary Structure: Local folding patterns stabilized by hydrogen bonds between backbone atoms. Common motifs are α-helix and β-pleated sheet.
- Tertiary Structure: The overall 3D conformation of a single polypeptide chain, stabilized by interactions between R-groups (hydrophobic interactions, ionic bonds, hydrogen bonds, disulfide bridges).
- Quaternary Structure: The arrangement of multiple polypeptide subunits (e.g., Hemoglobin has four subunits).
Macromolecular Nature of Proteins:
Biological and Pharmaceutical Importance:
- Biological Functions: Catalysis (enzymes), structure (collagen), transport (hemoglobin), defense (antibodies), regulation (hormones), movement (actin, myosin).
- Pharmaceutical Importance:
  - Therapeutic Proteins: Insulin (diabetes), human growth hormone, monoclonal antibodies (e.g., trastuzumab for cancer), clotting factors (e.g., Factor VIII for hemophilia).
  - Vaccines: Many vaccines contain proteins from pathogens (e.g., tetanus toxoid).
  - Diagnostic Reagents: Enzymes are used in diagnostic kits (e.g., glucose oxidase for blood glucose monitors).
  - Drug Targets: Many drugs work by binding to proteins (receptors, enzymes, ion channels).

d) Nucleic Acids

e) Vitamins

f) Hormones

g) Enzymes

Chemistry:
- Enzymes are biological catalysts, almost always proteins (with the exception of a small group of catalytic RNA molecules called ribozymes).
- Some enzymes require non-protein components for activity:
  - Cofactor: An inorganic ion (e.g., Zn²⁺, Mg²⁺, Fe²⁺).
  - Coenzyme: An organic molecule, often derived from vitamins (e.g., NAD⁺, FAD, CoA).
  - Prosthetic group: A coenzyme or metal ion that is tightly/covalently bound to the enzyme.
  - Holoenzyme = Apoenzyme (protein part) + Cofactor/Coenzyme.
Classification (by type of reaction catalyzed):
1. Oxidoreductases: Oxidation-reduction reactions (e.g., dehydrogenases, oxidases).
2. Transferases: Transfer of functional groups (e.g., kinases transfer phosphate).
3. Hydrolases: Cleavage of bonds with addition of water (e.g., esterases, proteases, peptidases).
4. Lyases: Cleavage of bonds without hydrolysis or oxidation (e.g., decarboxylases, aldolases).
5. Isomerases: Interconversion of isomers (e.g., isomerases, mutases).
6. Ligases (Synthetases): Joining of two molecules using ATP (e.g., DNA ligase).
Mode of Action:
- Enzymes work by binding to their specific substrate(s) at a region called the active site, forming an enzyme-substrate (ES) complex.
- This binding lowers the activation energy of the reaction, allowing it to proceed much faster.
- Models:
  - Lock and Key: The active site is pre-shaped to perfectly fit the substrate.
  - Induced Fit: The binding of the substrate induces a conformational change in the enzyme, which then fits snugly around the substrate.
Kinetics (Michaelis-Menten Equation):
- Describes the rate of enzyme-catalyzed reactions.
- V₀ = (Vmax [S]) / (Km + [S])
  - V₀: Initial reaction velocity.
  - [S]: Substrate concentration.
  - Vmax: Maximum velocity, when the enzyme is saturated with substrate.
  - Km (Michaelis Constant): Substrate concentration at half Vmax (V₀ = Vmax/2).
- Lineweaver-Burk Plot (Double Reciprocal Plot): A linear transformation of the Michaelis-Menten equation (1/V₀ vs 1/[S]) used to accurately determine Km and Vmax and to study enzyme inhibition.
Inhibition:
- Irreversible Inhibition: Inhibitor binds covalently and permanently inactivates the enzyme. Pharmaceutical Application: Many toxic substances (e.g., heavy metals, nerve gas) are irreversible inhibitors. Some drugs are designed as irreversible inhibitors (e.g., aspirin inhibits COX enzyme irreversibly; penicillin inhibits bacterial transpeptidase irreversibly).
- Reversible Inhibition: Inhibitor binds non-covalently and can be removed.
  - Competitive Inhibition: Inhibitor competes with substrate for the active site. It resembles the substrate’s structure. It increases the apparent Km (affinity decreases), but Vmax remains the same. Pharmaceutical Application: Many statins (for cholesterol), sulfa drugs (antibacterial), and methotrexate (cancer) are competitive inhibitors.
  - Non-competitive Inhibition: Inhibitor binds to a site other than the active site (allosteric site), changing the enzyme’s shape so it’s less effective. Vmax decreases, but Km remains the same.
  - Uncompetitive Inhibition: Inhibitor binds only to the ES complex.
Activation:
- Zymogens (Proenzymes): Inactive precursors of enzymes that are activated by proteolytic cleavage. This prevents unwanted digestion. Examples: Pepsinogen (stomach) → Pepsin; Trypsinogen (pancreas) → Trypsin; Clotting factors in blood.
- Allosteric Activation: Binding of an activator molecule at an allosteric site increases enzyme activity.
Specificity:
Allosteric Enzymes:
- Enzymes that have binding sites for regulatory molecules (effectors or modulators) separate from the active site. Binding of an effector causes a conformational change that alters the enzyme’s activity (either inhibits or activates). They are key in metabolic regulation and often show sigmoidal kinetics.
Factors Affecting the Rate of an Enzyme-Catalyzed Reaction:
1. Substrate Concentration [S]: Rate increases until Vmax is reached.
2. Enzyme Concentration [E]: Rate is directly proportional to [E] (at saturating [S]).
3. Temperature: Rate increases with temperature until an optimum (usually ~37°C for human enzymes), then declines as the enzyme denatures.
4. pH: Each enzyme has an optimum pH where its structure and activity are maximal (e.g., pepsin ~pH 2, trypsin ~pH 8).
5. Inhibitors and Activators.
Biological and Pharmaceutical Importance:
Mechanism of Action of Important Enzymes:

PHARM 313: PHYSIOLOGY-A – DETAILED NOTES

Course Title: Physiology-A
Course Code: PHARM 313
Credit Hours: 03

Course Objective: To describe the basic physiological processes that form the basis of pathophysiology (how diseases disrupt these processes) and their ultimate link with pharmacology (how drugs act to restore normal function).

1. BASIC CELL FUNCTIONS

This section covers the fundamental “building blocks” and “operating systems” of the human body, starting from atoms and ending with how substances move in and out of cells.

a. Chemical Composition of the Body

b. Cell Structure

c. Protein Activity and Cellular Metabolism

Binding Site Characteristics:
- Proteins (e.g., enzymes, receptors, transporters) have specific regions called binding sites where other molecules (ligands) can bind.
- Characteristics:
  - Specificity: The site is shaped to bind only certain ligands (like a lock and key).
  - Affinity: The strength of the binding. High affinity means the ligand binds tightly even at low concentrations.
- Pharmaceutical Relevance: This is the basis of drug action. A drug is a ligand that binds to a specific protein target (e.g., a receptor). Drug design aims to create molecules with high specificity and appropriate affinity for their target.
Regulation of Binding Site Characteristics:
Chemical Reactions and Enzymes:
- Chemical Reactions: Processes that convert reactants into products (e.g., A + B → C).
- Enzymes: Protein catalysts that speed up chemical reactions without being consumed. They lower the activation energy required for the reaction.
- Pharmaceutical Relevance: As covered in PHARM 312, enzymes are major drug targets. By inhibiting an enzyme, a drug can block a specific metabolic pathway (e.g., ACE inhibitors block the enzyme that produces angiotensin II, lowering blood pressure).
Regulation of Enzyme-Mediated Reactions:
- Rate is controlled by factors like substrate concentration, product feedback inhibition, allosteric regulation, and covalent modification.
Multienzyme Metabolic Pathways:
- Series of enzymes working in sequence, where the product of one enzyme becomes the substrate for the next (e.g., glycolysis, Krebs cycle).
- Pharmaceutical Relevance: A drug that inhibits just one enzyme in a pathway can effectively shut down the entire pathway.
ATP (Adenosine Triphosphate):
- The primary energy currency of the cell. Hydrolysis of ATP to ADP + Pi releases energy to drive cellular work (muscle contraction, protein synthesis, active transport).
Cellular Energy Transfer (Metabolism):
- Catabolism: Breakdown of complex molecules (carbs, fats, proteins) to release energy, which is captured in ATP.
- Anabolism: Synthesis of complex molecules (proteins, nucleic acids) required by the cell, using energy from ATP.
Carbohydrate, Fat, and Protein Metabolism:
- Carbohydrate Metabolism: Glucose is broken down via glycolysis (in cytoplasm) to pyruvate, which enters the Krebs cycle (in mitochondria) for complete oxidation to CO₂ and H₂O, yielding lots of ATP.
- Fat Metabolism: Fats are broken down to fatty acids and glycerol. Fatty acids undergo beta-oxidation to produce acetyl-CoA, which feeds into the Krebs cycle.
- Protein Metabolism: Amino acids can be deaminated (nitrogen removed) and the carbon skeletons used for energy or converted to glucose or fats.
Essential Nutrients:
- Substances the body cannot synthesize and must obtain from the diet. This includes essential amino acids (e.g., histidine, lysine), essential fatty acids (e.g., linoleic acid), vitamins, and minerals.

d. Genetic Information and Protein Synthesis

e. Movement of Molecules across Cell Membranes

This is a cornerstone of pharmacology, as it determines how drugs get into, and out of, cells and the body.

BIOLOGICAL CONTROL SYSTEM

This section explains how the body maintains stability (homeostasis) and coordinates complex functions through the nervous and endocrine systems.

a. Homeostatic Mechanisms and Cellular Communication

General Characteristics:
- Homeostasis is the maintenance of a relatively stable internal environment despite external changes. It is a dynamic process, not a fixed state.
- Pharmaceutical Relevance: Most diseases represent a failure of homeostasis (e.g., diabetes = failure to regulate blood glucose; hypertension = failure to regulate blood pressure). Drugs are designed to help restore homeostasis.
Components of Homeostatic Control Systems:
- All homeostatic control systems have three basic components:
  1. Receptor (Sensor): Detects a change in the internal environment (a stimulus).
  2. Integrating Center (Control Center): Receives input from the receptor, processes the information, and determines the appropriate response (e.g., brain, spinal cord, endocrine gland).
  3. Effector: Carries out the response ordered by the integrating center to counteract the stimulus (e.g., muscles, glands, organs).
- Negative Feedback: The most common mechanism. The response reverses the direction of the initial stimulus, reducing the output. This keeps a variable within a normal range.
  - Example: Body temperature rises → receptors sense this → brain (integrating center) activates sweat glands (effector) → sweating cools the body → temperature returns to normal.
  - Pharmaceutical Relevance: Many drugs work by enhancing or blocking parts of a negative feedback loop.
- Positive Feedback: The response amplifies the initial stimulus, pushing the variable further away from its starting point. This leads to an escalating cycle until a logical endpoint. It is less common.
  - Example: Childbirth. Oxytocin release causes uterine contractions, which push the baby against the cervix. This stretching signals the brain to release more oxytocin, leading to stronger contractions, more stretching, and so on, until the baby is delivered.
  - Pharmaceutical Relevance: Positive feedback loops can be involved in pathological conditions (e.g., the rapid depolarization phase of an action potential, or vicious cycles in inflammation).
Intercellular Chemical Messengers:
Processes Related to Homeostasis:
Receptors:
- Proteins, usually on the cell membrane or inside the cell, that bind specifically to a chemical messenger (ligand). Binding triggers a cellular response.
- Pharmaceutical Relevance: Receptors are the primary targets for a huge number of drugs. Drugs can be agonists (bind and activate the receptor, mimicking the natural messenger) or antagonists (bind and block the receptor, preventing activation).
Signal Transduction Pathways:
- The process by which a chemical messenger (the “first messenger”) binding to a receptor on the cell surface creates a signal inside the cell. This often involves:
  1. Receptor activation.
  2. Activation of a G-protein (a middleman protein).
  3. Activation or inhibition of an effector enzyme (e.g., adenylyl cyclase).
  4. Change in the level of a second messenger inside the cell (e.g., cAMP, Ca²⁺, IP₃, DAG).
  5. The second messenger triggers a cascade of events, ultimately leading to the cell’s response (e.g., enzyme activation, gene transcription, ion channel opening). This cascade greatly amplifies the original signal.
- Pharmaceutical Relevance: Many drugs target specific steps in these pathways (e.g., drugs that block G-proteins, or drugs that mimic or block second messengers).

b. Neural Control Mechanisms

Structure and Maintenance of Neurons:
Functional Classes of Neurons:
1. Afferent (Sensory) Neurons: Transmit information from the body’s sensory receptors (skin, eyes, internal organs) to the central nervous system (CNS – brain and spinal cord).
2. Efferent (Motor) Neurons: Transmit commands from the CNS to effectors (muscles, glands).
3. Interneurons: Located entirely within the CNS. They connect sensory and motor neurons and are involved in reflexes, learning, memory, and complex processing. They are the most abundant type.
Glial Cells (Neuroglia):
Neural Growth and Regeneration:
- In the PNS, damaged axons can regenerate with the help of Schwann cells. In the CNS, regeneration is very limited due to inhibitory factors from glial cells, which is why spinal cord injuries are often permanent.
Basic Principles of Electricity:
- Voltage (Potential Difference): The difference in electrical charge between two points (measured in volts).
- Current: The flow of charged particles (ions) (measured in amperes).
- Resistance: Opposition to current flow.
The Resting Membrane Potential:
Graded Potentials and Action Potentials:
- Graded Potentials: Local changes in membrane potential that occur in dendrites and cell bodies. They are short-distance signals that decrease in strength as they spread. They can be depolarizing (less negative, excitatory) or hyperpolarizing (more negative, inhibitory).
- Action Potentials (APs): The long-distance signals of the axon. If a graded potential depolarizes the axon hillock (trigger zone) to a critical level called threshold (around -55 mV), it triggers an all-or-none AP.
  - Phases:
    1. Depolarization: Voltage-gated sodium channels open. Na⁺ rushes into the cell, causing the inside to become positive.
    2. Repolarization: Sodium channels inactivate. Voltage-gated potassium channels open. K⁺ rushes out of the cell, restoring the negative charge inside.
    3. Hyperpolarization/Afterpotential: Potassium channels close slowly, causing a slight overshoot.
  - Propagation: The AP is regenerated along the length of the axon. In myelinated axons, the AP jumps from one Node of Ranvier (gap in myelin) to the next in a process called saltatory conduction, which is much faster.
- Pharmaceutical Relevance: Many drugs, toxins, and diseases work by affecting ion channels (e.g., local anesthetics like lidocaine block voltage-gated Na⁺ channels, preventing AP generation and thus pain sensation).
Functional Anatomy of Synapses:
- The junction between two neurons or between a neuron and an effector cell (muscle, gland).
- Presynaptic Terminal: Contains vesicles filled with neurotransmitter.
- Synaptic Cleft: The tiny gap between the cells.
- Postsynaptic Membrane: Contains receptors for the neurotransmitter.
Activation of the Postsynaptic Cell:
1. An AP arrives at the presynaptic terminal.
2. Voltage-gated calcium channels open, allowing Ca²⁺ to enter.
3. Ca²⁺ influx causes synaptic vesicles to fuse with the membrane, releasing neurotransmitter into the cleft.
4. Neurotransmitter binds to receptors on the postsynaptic membrane.
5. This causes ion channels to open or close, producing a postsynaptic potential (a graded potential).
  - EPSP (Excitatory Postsynaptic Potential): Depolarizing, makes the neuron more likely to fire an AP (e.g., due to Na⁺ influx).
  - IPSP (Inhibitory Postsynaptic Potential): Hyperpolarizing, makes the neuron less likely to fire an AP (e.g., due to K⁺ efflux or Cl⁻ influx).
6. The neurotransmitter is rapidly removed from the cleft (by degradation, reuptake into the presynaptic terminal, or diffusion) to terminate the signal.
Synaptic Effectiveness:
Neurotransmitters and Neuromodulators:
- Neurotransmitters: Classic, fast-acting messengers (e.g., acetylcholine, glutamate (excitatory), GABA (inhibitory), norepinephrine, dopamine, serotonin).
- Neuromodulators: Slower-acting, longer-lasting effects that modulate the effectiveness of synaptic transmission (e.g., neuropeptides like endorphins).
- Pharmaceutical Relevance: This is the site of action for a vast number of drugs.
  - Agonists: Nicotine (ACh receptor agonist), Morphine (opioid receptor agonist).
  - Antagonists: Atropine (muscarinic ACh receptor antagonist), many antipsychotics (dopamine antagonists).
  - Reuptake Inhibitors: SSRIs like fluoxetine (Prozac) block serotonin reuptake, increasing its effect in the synapse.
  - Degradation Inhibitors: Neostigmine inhibits acetylcholinesterase (the enzyme that breaks down ACh), prolonging its action.
Neuroeffector Communication:
Central Nervous System (CNS):
- Spinal Cord:
  - Functions: 1) Conducts information to and from the brain. 2) Integrates reflexes (automatic, rapid responses to stimuli, like the knee-jerk reflex).
- Brain: Major divisions:
  - Brainstem (Medulla, Pons, Midbrain): Controls basic life-support functions (breathing, heart rate, blood pressure, sleep-wake cycles).
  - Cerebellum: Coordinates movement, balance, and posture.
  - Diencephalon (Thalamus, Hypothalamus): Thalamus is a relay station for sensory information. Hypothalamus is the master regulator of homeostasis (body temp, hunger, thirst, and controls the pituitary gland).
  - Cerebrum (Cerebral Hemispheres): Responsible for higher functions: conscious thought, memory, language, sensory perception, voluntary movement. Divided into lobes (frontal, parietal, temporal, occipital).
Peripheral Nervous System (PNS):
- Afferent Division: Sensory input to CNS.
- Efferent Division: Motor output from CNS. Divided into:
  - Somatic Nervous System: Voluntary control of skeletal muscles. Uses ACh as the primary neurotransmitter.
  - Autonomic Nervous System (ANS): Involuntary control of smooth muscle, cardiac muscle, and glands. Divided into:
    - Sympathetic Nervous System: “Fight or flight.” Prepares the body for action (increases heart rate, dilates pupils, diverts blood to muscles). Uses norepinephrine at most effectors.
    - Parasympathetic Nervous System: “Rest and digest.” Conserves energy and promotes maintenance activities (slows heart rate, stimulates digestion). Uses ACh at effectors.
- Pharmaceutical Relevance: The ANS is a major target for drugs. Sympathomimetics mimic the sympathetic system (e.g., epinephrine for anaphylaxis). Sympatholytics block it (e.g., beta-blockers for hypertension). Parasympathomimetics (e.g., pilocarpine for dry mouth) and Parasympatholytics (e.g., atropine for surgery) are also crucial.
Blood Supply, Blood-Brain Barrier (BBB), and Cerebrospinal Fluid (CSF):
- BBB: A highly selective permeability barrier formed by tight junctions between capillary endothelial cells in the brain, reinforced by astrocytes. It protects the brain from toxins and pathogens but also prevents many drugs from entering.
- Pharmaceutical Relevance: A major challenge in treating brain disorders (e.g., brain tumors, Parkinson’s, Alzheimer’s) is designing drugs that can cross the BBB. Lipid-soluble drugs (e.g., diazepam) can cross; water-soluble drugs generally cannot.
- CSF: A clear fluid produced in the brain’s ventricles that cushions the brain and spinal cord, removes waste, and provides buoyancy.

c. The Sensory Systems

Receptors: Sensory receptors are specialized cells that detect specific stimuli (light, sound, pressure, chemicals).
- Types: Chemoreceptors, Mechanoreceptors, Photoreceptors, Thermoreceptors, Nociceptors (pain).
Neural Pathways in Sensory System: Stimuli are detected by receptors → converted into graded potentials → if threshold is reached, action potentials are generated and travel along afferent neurons to the spinal cord and then to specific areas of the brain (e.g., touch to somatosensory cortex, vision to occipital cortex).
Association Cortex and Perceptual Processing: The primary sensory cortices receive basic information. The association cortex integrates this information with memory and past experience to create conscious perception (e.g., recognizing a face or understanding spoken words).
Primary Sensory Coding: The nervous system encodes information about stimulus type (modality), location, intensity (by frequency of APs and number of receptors activated), and duration.
Somatic Sensation: Sensations from the body surface and deep tissues. Includes touch, pressure, vibration, temperature, pain (nociception), and proprioception (awareness of body position).
Vision, Hearing, Vestibular System (Balance), Chemical Senses (Taste and Smell):

d. Principles of Hormonal Control Systems

Hormone Structures and Synthesis: Hormones are chemically diverse (peptides/proteins, steroids, amines). Their synthesis location and process depend on their type.
Hormone Transport in the Blood:
- Water-soluble hormones (peptides, catecholamines): Dissolve in plasma and travel freely.
- Lipid-soluble hormones (steroids, thyroid hormone): Require carrier proteins (e.g., albumin, specific binding globulins) for transport in the blood.
Hormone Metabolism and Excretion: Hormones are eventually broken down (mainly in the liver and kidneys) and excreted. The half-life of a hormone in the blood depends on these processes.
Mechanisms of Hormone Action:
- Lipid-soluble hormones: Diffuse across the cell membrane, bind to intracellular (cytoplasmic or nuclear) receptors. The hormone-receptor complex then binds to DNA and alters gene transcription, leading to protein synthesis. This is a slow process.
- Water-soluble hormones: Cannot cross the membrane. They bind to cell-surface receptors and use signal transduction pathways (e.g., cAMP, IP₃/DAG) to trigger rapid cellular responses.
Inputs that Control Hormone Secretion:
- Humoral Stimuli: Changes in blood levels of ions or nutrients (e.g., high blood glucose stimulates insulin release).
- Neural Stimuli: Nerve fibers directly stimulate hormone release (e.g., sympathetic nervous system stimulates epinephrine release from adrenal medulla).
- Hormonal Stimuli: A hormone stimulates the release of another hormone (e.g., hypothalamic hormones stimulate pituitary hormone release).
Control Systems Involving the Hypothalamus and Pituitary:
- The hypothalamus is the master link between the nervous and endocrine systems. It secretes releasing and inhibiting hormones into a special portal blood system that carries them to the anterior pituitary. These hormones control the secretion of anterior pituitary hormones (e.g., growth hormone, TSH, ACTH, FSH, LH). The posterior pituitary stores and releases hormones (oxytocin, ADH) produced by the hypothalamus.
Candidate Hormones: Some chemical messengers act in a paracrine manner but are sometimes considered “candidate hormones” (e.g., somatostatin).
Types of Endocrine Disorders:
1. Hyposecretion: Too little hormone (e.g., Type 1 diabetes – low insulin).
2. Hypersecretion: Too much hormone (e.g., Cushing’s syndrome – high cortisol).
3. Hyporesponsiveness: Target cells do not respond properly (e.g., Type 2 diabetes – insulin resistance).
- Pharmaceutical Relevance: Treatment involves replacing the missing hormone (insulin, levothyroxine), blocking the synthesis or action of an over-secreted hormone, or using drugs that mimic or block hormone action.

e. Muscle

Structure: Three types: Skeletal (voluntary, striated), Smooth (involuntary, non-striated, in organs), Cardiac (involuntary, striated, in heart). All are composed of muscle fibers (cells) containing myofibrils, which are made of repeating units called sarcomeres. Sarcomeres contain the contractile proteins actin (thin filament) and myosin (thick filament) .
Molecular Mechanisms of Contraction (Sliding Filament Mechanism):
- Myosin heads bind to actin, forming cross-bridges. Using energy from ATP, the myosin heads pivot, pulling the actin filaments toward the center of the sarcomere. This shortens the muscle fiber.
Mechanics of Single Fiber Contraction:
Skeletal Muscle Energy Metabolism:
- ATP for contraction is generated from creatine phosphate (immediate), glycolysis (anaerobic), and oxidative phosphorylation (aerobic).
Types of Skeletal Muscle Fibers:
- Slow-twitch (Type I): Oxidative, fatigue-resistant (for posture, endurance).
- Fast-twitch (Type II): Glycolytic, fatigue quickly (for rapid, powerful movements).
Whole Muscle Contraction:
- The force of contraction depends on the number of motor units recruited and the frequency of stimulation. Summation and tetanus (a smooth, sustained contraction) occur with high-frequency stimulation.
Structure, Contraction, and its Control:
- Skeletal Muscle: Contraction is initiated by ACh release from motor neurons at the neuromuscular junction. An action potential in the muscle fiber triggers Ca²⁺ release from the sarcoplasmic reticulum, which allows the actin-myosin interaction to occur.
- Smooth Muscle: Contraction is slower and more prolonged. It is controlled by the ANS, hormones, and local factors. Ca²⁺ triggers contraction, but the mechanism is different (calmodulin, not troponin).
- Cardiac Muscle: Contraction is similar to skeletal muscle but is autorhythmic (can generate its own action potentials). It is controlled by the ANS and hormones.
- Pharmaceutical Relevance: Muscle is a target for many drugs. Muscle relaxants (e.g., for surgery) act at the neuromuscular junction. Drugs for asthma (e.g., albuterol) relax bronchial smooth muscle. Drugs for hypertension (e.g., calcium channel blockers) relax vascular smooth muscle. Drugs for heart failure (e.g., digoxin) increase the force of cardiac muscle contraction.

f. Control of Body Movement

Motor Control Hierarchy: Movement is controlled at multiple levels:
1. Local Level (Spinal Cord): Reflexes and basic coordination (e.g., stretch reflex).
2. Projection Level (Brain Motor Centers): Includes the motor cortex (plans and initiates voluntary movement), cerebellum (coordinates movement and balance), and basal ganglia (initiates and smoothes movements, inhibits unwanted movements).
3. Pre-command Level: Higher brain areas that set the overall goal and strategy for movement.
Local Control of Motor Neurons: Sensory feedback from muscles (muscle spindles, Golgi tendon organs) at the spinal level helps regulate muscle length and tension via reflexes.
The Brain Motor Centers and the Descending Pathways they Control:
- The motor cortex sends commands via descending pathways (e.g., corticospinal tract) to spinal motor neurons.
- The cerebellum and basal ganglia modulate these commands.
Muscle Tone: A state of partial, continuous contraction of muscles, important for maintaining posture. It is maintained by a low level of neural input.
Maintenance of Upright Posture and Balance:
- Involves input from the vestibular system (inner ear), vision, and proprioceptors (from muscles and joints), integrated by the brainstem and cerebellum to make constant, small adjustments.
Walking: A complex, rhythmic activity generated by central pattern generators in the spinal cord, modulated by input from the brain and sensory feedback.

g. Consciousness and Behavior

State of Consciousness: A continuum ranging from full alertness to sleep. It is controlled by the reticular activating system (RAS) in the brainstem, which projects to the thalamus and cortex to keep them awake and alert.
- Pharmaceutical Relevance: Sedatives, anesthetics, and sleeping pills work by depressing the RAS or other brain areas.
Conscious Experiences: The result of widespread cortical activity integrating sensory information with memory and emotion.
Motivation and Emotion:
- Motivation: The drive to fulfill a need (e.g., hunger, thirst). It involves the hypothalamus and limbic system.
- Emotion: Complex states involving subjective feelings, physiological responses (e.g., increased heart rate), and behavioral expression. The limbic system (including the amygdala, hippocampus, and parts of the thalamus/cortex) is the primary center.
- Pharmaceutical Relevance: Many psychiatric drugs target these systems (e.g., antidepressants, antipsychotics, anxiolytics).
Altered States of Consciousness:
- Can be induced by drugs (e.g., alcohol, anesthetics, hallucinogens), meditation, or trauma.
Learning and Memory:
- Learning: The acquisition of new information or skills.
- Memory: The storage and retrieval of that information.
- Types: Short-term (working) memory, long-term memory (explicit/declarative and implicit/procedural). The hippocampus is crucial for forming new long-term memories.
- Pharmaceutical Relevance: Drugs are being developed to enhance memory in conditions like Alzheimer’s disease (e.g., cholinesterase inhibitors).
Cerebral Dominance and Language:
- In most people, the left hemisphere is dominant for language functions (speech, writing, comprehension). Key language areas include Broca’s area (speech production) and Wernicke’s area (language comprehension).
- The right hemisphere is often more dominant for spatial awareness, art, and music.